Results 71 to 80 of about 61,981 (265)

Editor's Note

open access: yesScottish Studies
Virginia Blankenhorn
doaj   +1 more source

Ethical challenges of emerging anatomical technologies in UK public engagement

open access: yesAnatomical Sciences Education, EarlyView.
Emergent technologies are increasingly used in anatomical education and public engagement. They expand access and reduce reliance on physical human tissue, but also introduce ethical challenges relating to consent, dignity, representation, transparency, and commercialization.
Lucy E. Hyde   +3 more
wiley   +1 more source

One‐Step Electrodeposition of Iron Oxyhydroxide Onto 3D Porous Graphene Substrates for on Chip Asymmetric Micro‐Supercapacitors

open access: yesBatteries &Supercaps, Volume 8, Issue 3, March 2025.
A micro‐supercapacitor with electrodeposited iron oxyhydroxide (FeOOH) as the negative electrode and birnessite manganese oxide (MnO2) as the positive electrode achieves a 2 V working voltage, stable cycling in an aqueous electrolyte, and high energy and power densities of 21 μWh cm‐2 and 2.5 mW cm‐2 respectively.
Filipe Braga   +6 more
wiley   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer   +4 more
wiley   +1 more source

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari   +2 more
wiley   +1 more source

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Background Regulatory guidance in the United Kingdom advises DPYD genotyping prior to fluoropyrimidine‐based treatment. This economic evaluation estimated the costs and outcomes associated with DPYD screening prior to prescribing fluoropyrimidines for colorectal cancer in Wales and also considers additional variants to those included in ...
Catrin O. Plumpton   +8 more
wiley   +1 more source

The Macmillan-Scottish ambulance partnership: driving change in end-of-life care. [PDF]

open access: yesBMJ Support Palliat Care
McFerran E   +5 more
europepmc   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm   +2 more
wiley   +1 more source

Economic evaluations of antiobesity medications: A systematic literature review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The global prevalence of obesity is rising rapidly. With several antiobesity medications approved and many more in development, understanding their economic value is increasingly important. This study reviews full economic evaluations of approved antiobesity medications to assess cost‐effectiveness and inform reimbursement and access decisions.
Martina Jurković   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy